TB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology

Similar documents
Tuberculosis Epidemiology

TB in California: Costs, Transmission, and Selecting from the Latent Pool

TB-Free California: How close are we? How can we get closer?

TB trends and TB genotyping

2016 Annual Tuberculosis Report For Fresno County

Tuberculosis in Chicago 2006

2014 Annual Report Tuberculosis in Fresno County. Department of Public Health

Global TB Burden, 2016 estimates

Tuberculosis in Alameda County, 2009

TB Infection Who is Testing and Treating? TB Control and Elimination: Current Dilemma. Span of TB Control: 2010

The Epidemiology of Tuberculosis in Minnesota,

2015 Annual Report Tuberculosis in Fresno County. Department of Public Health

Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010

2008 Tuberculosis Report

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

Tuberculosis Populations at Risk

Epidemiology of Tuberculosis in the Northeast Region of the United States Surveillance Data Source. States included in the Northeast Region

Tuberculosis in Chicago 2007

Pediatric Tuberculosis in Los Angeles County: An Update

Tuberculosis in Alameda County, 2012

Tuberculosis in Alameda County, 2014 Alameda County Public Health Department

ANNUAL TUBERCULOSIS REPORT OREGON Oregon Health Authority Public Health Division TB Program November 2012

Report on Tuberculosis in California, 2012

Trends in U.S. HIV Diagnoses,

The Tip of the Iceberg: Addressing Latent Tuberculosis Infection to Accelerate Tuberculosis Elimination

HIV as a Risk Factor for TB Henry Pacheco, MD November 13, 2008

2014 TUBERCULOSIS FACT SHEET A Profile of Mecklenburg County Reported Cases

HIV and AIDS in the United States

Tuberculosis Elimination Jennifer Flood, MD, MPH Pennan Barry, MD, MPH NAR-NTCA February 25, 2016

Global, National, Regional

WASHINGTON STATE COMMUNICABLE DISEASES OF PUBLIC HEALTH SIGNIFICANCE FOR THE CIVIL SURGEON

Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination

Annual Tuberculosis Report Oregon 2007

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Disclosures. TB and CoMorbidities Challenges and Opportunities. Burden of TB. Outline of the lecture. Target testing for TB Infection TB HIV 3/25/2012

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

Global, National, Regional

Haley Blake Sage Nagai, MPH. Disease Investigation and Intervention Specialists Tuberculosis Treatment and Control Clinic

Laboratory Reporting of Tuberculosis Test Results and Patient Treatment Initiation in California

Disclosures. Updates in TB for the PCP: Opportunities for Prevention. Objectives PART 1: WHY TEST? 4/14/2016. None

Epidemiology of Tuberculosis Denver TB Course

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

Persons Living with HIV/AIDS, San Mateo County Comparison

ACTIVE TUBERCULOSIS IN MACOMB COUNTY, A Review of TB Program Data,

Trends in HIV Incidence and Prevalence in the United States

Tuberculosis in Alameda County, 2011

4. Chlamydia. Treatment: Treating infected patients prevents further transmission to sex partners. In addition, treatment of chlamydia in pregnant

The American Experience with TB Elimination

LTBI: Who to Test & When to Treat

Epidemiology of HIV Among Women in Florida, Reported through 2014

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

TB in Foreign Born and High Risk Populations

California s Experiences Using Tuberculosis Whole Genome Sequencing

HIV Surveillance in Urban and Nonurban Areas. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention

The authors assessed drug susceptibility patterns

LATENT TUBERCULOSIS SCREENING AND TREATMENT:

New Jersey HIV/AIDS Epidemiologic Profile 2011

HIV Incidence Report, Sexually Transmitted Diseases, HIV and Tuberculosis Section, Epidemiology and Surveillance Unit

Essential Mycobacteriology Laboratory Services in the Era of MDR- and XDR-TB: A TB Controller s Perspective

California TB program updates

Karen E. Kim, MD Professor of Medicine Dean for Faculty Affairs Director, Center for Asian Health Equity University of Chicago

11/1/2017. Disclosures. Update In Tuberculosis, Indiana Outline/Objectives. Pathogenesis of M.tb Global/U.S. TB Burden, 2016

State of the State in TB Control

California s Experiences Using Tuberculosis Whole Genome Sequencing

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

2013 Annual Report Tuberculosis in Fresno County. Department of Public Health

Tuberculosis: The Big Picture And Challenge of Drug-resistance

ELIMINATING HEALTH DISPARITIES IN AN URBAN AREA. VIRGINIA A. CAINE, M.D., DIRECTOR MARION COUNTY HEALTH DEPARTMENT INDIANAPOLIS, INDIANA May 1, 2002

2009 ANNUAL TUBERCULOSIS MORBIDITY REPORT

Mortality Slide Series. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention

26/09/2014. Types of Viral Hepatitis. Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges

TOBACCO USE AND ETHNICITY

Communicable Diseases

Latent Tuberculosis Infection Reporting Instructions for Civil Surgeons Using CalREDIE Provider Portal

Arizona Annual Tuberculosis Surveillance Report

HIV & AIDS Cases in Alameda County

Tuberculosis and the Asian Population of Tarrant County, TX. By: Jessica McCallister

Diagnosis and Medical Management of Latent TB Infection

Outline. Tuberculosis (TB) Medical Evaluation for TB 5/5/2014. Chest Radiograph with Lower Lobe Cavity

Contact Investigation San Antonio, Texas January 14-15, 2013

HIV/AIDS EPIDEMIOLOGY. Rachel Rivera, MD Assistant Professor Infectious Diseases UT Southwestern Medical Center November 14, 2014

Tuberculosis Elimination

Demographics and Health Data

Demographics and Health Data

Yakima Health District BULLETIN

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY.

Tuberculosis: Where Are We Now?

ILI Syndromic Surveillance

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

Syphilis Cook County Department of Public Health

2017 HIV/AIDS Epidemiology Update 2016 Data. James Dowling Health Program Coordinator Division of Public Health

State Of Tuberculosis Elimination in the United States, 2017

Changing Patient Base. A Knowledge to Practice Program

Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges

2018 HIV/AIDS Epidemiology Update 2017 Data. James Dowling Health Program Coordinator Division of Public Health

Sexually Transmitted Diseases, Hepatitis C and HIV Epidemiology in North Dakota

Tuberculosis in Alaska 1999

Transcription:

TB EPIDEMIOLOGY TB Clinical Intensive Course Curry International Tuberculosis Center September 30, 2015 Varsha Nimbal, MPH Tuberculosis Control Branch California Department of Public Health 1 Outline TB epidemiology Global burden United States California Summary of surveillance data Demographic characteristics Clinical characteristics Summary 2 Estimated Global TB Burden, 2013 9 million incident cases; 1.1 million HIV positive 126 cases per 100,000 population 1.5 million deaths 360,000 HIV Positive 480,000 developed MDR WHO, Global Tuberculosis Control 2014 3 1

4 TB Epidemiology United States 5 30,000 Reported TB Cases United States, 1982 2013 25,000 No. of Cases 20,000 15,000 10,000 5,000 0 6 2

TB Morbidity United States, 2008 2013 Year No. Rate 2008 12,893 4.2 2009 11,519 3.8 2010 11,164 3.6 2011 10,509 3.4 2012 9,940 3.2 2013 9,582 3.0 2014* 9, 412 3.0 *Provisional Results from CDC MMWR 2015; 64(10); 265 269 7 8 Reported TB Cases by Age Group, United States, 2013 65 yrs (23%) <15 yrs (5%) 15-24 yrs (10%) 45-64 yrs (31%) 25-44 yrs (31%) 9 3

TB Case Rates by Age Group and Sex, United States, 2013 10 Reported TB Cases by Race/Ethnicity,* United States, 2013 *All races are non Hispanic. Persons reporting two or more races accounted for less than 1% of all cases. 11 TB Case Rates by Race/Ethnicity, United States, 2003 2013 40.0 30.0 Cases per 100,000 20.0 10.0 0.0 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 American Indian or Alaska Native Black or African American White Asian Native Hawaiian or Other Pacific Islander Hispanic or Latino 12 4

Number of TB Cases in U.S. born vs. Foreign born Persons, United States, 1993 2013 13 TB Case Rates in U.S. born vs. Foreign born Persons, United States,1993 2013 Cases per 100,000 14 Countries of Birth of Foreign born Persons Reported with TB, United States, 2013 15 5

Primary Anti TB Drug Resistance, United States, 1993 2013 % Resistant Note: Based on initial isolates from persons with no prior history of TB. Multidrug resistant TB (MDR TB) is defined as resistance to at least isoniazid and rifampin. 16 % Resistant 14 12 10 8 6 4 2 0 Primary Isoniazid Resistance in U.S. born vs. Foreign born Persons, United States, 1993 2013 U.S. born Foreign born Note: Based on initial isolates from persons with no prior history of TB. 17 Primary MDR TB in U.S. born vs. Foreign born Persons United States, 1993 2013 % Resistant Note: Based on initial isolates from persons with no prior history of TB. MDR TB defined as resistance to at least isoniazid and rifampin. 18 6

TB Epidemiology California 19 6,000 5,000 4,000 3,000 2,000 1,000 0 Number of Tuberculosis Cases: California, 1988 2014 Year Number of Tuberculosis Cases and Case Rates: California, 2005 2014 Case Rate per 100,000 Number of Cases Case Rate per 100,000 Population National Case Rate (3.0 per 100,000) * 7

Tuberculosis in California, 2014 Tuberculosis Case Rates per 100,000 Population: California, 2014 >= 5.6 (state average) 3.0-5.6 < 3.0 (national average) < 5 cases Note: The map illustrates TB case rates by reporting jurisdiction in 2014. Thirteen jurisdictions (including Long Beach, not represented) had TB case rates equal to or above the state average of 5.6 cases per 100,000 population. Eight jurisdictions had tuberculosis case rates below the 2014 national rate of 3.0 per 100,000 population. Eleven jurisdictions (including Pasadena and Berkeley, not represented) had case rates greater than the national rate or less than the state rate (3.0 to 5.6 cases per 100,000 population). Case rates were not calculated for 29 jurisdictions because there were fewer than five cases in these areas. CA Epidemiology Reflects Global Epidemiology 23 Tuberculosis Cases by Country of Origin: California, 2014 Unknown 14 ( 0.7%) U.S.-born 463 (21.6%) Foreign-born 1,670 (77.8%) All Others 404 (24.2%) Mexico 450 (26.9%) India 96 (5.7%) China 160 (9.6%) Vietnam 205 (12.3%) Philippines 355 (21.3%) 8

Tuberculosis Cases in Foreign born and U.S. born Persons: California, 2005 2014 Tuberculosis Cases by Race/Ethnicity: California, 2014 Black 118 (5.5%) White Non-Hispanic 165 (7.7%) American Indian/ Alaska Native 4 (0.2%) 79 Asian/Pacific Islander 1,081 (50.3%) Hispanic 776 (36.1%) How do TB Cases Occur in California? Importation TB within 1 year of US arrival 835 of 11,149 cases 2010 2014 occurred within 1 year of arrival in US 7.5% Reactivation of remote infection Cases not from importation or recent transmission: 75.5% ~2,000 TB Cases Per Year Recent Transmission 26% genotype clustering within county (3 year window) 8% with indication of transmission within 2 years on RVCT Midpoint = 17% Thanks to Pennan Barry 9

Tuberculosis Cases by HIV/AIDS Diagnosis*: California, 2004-2013 Number of Tuberculosis Cases with HIV/AIDS Percent of Tuberculosis Cases with HIV/AIDS Number of Cases with HIV/AIDS * Match found in HIV/AIDS Registry, California Office of AIDS Figure 12. HIV/AIDS-associated Tuberculosis* by Race/Ethnicity: California, 2004-2013 Number of Cases with HIV/AIDS 150 125 100 75 50 25 0 Asian/Pacific Islander Black Hispanic White American Indian/Alaska Native 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Year * Match found in HIV/AIDS Registry, California Office of AIDS Figure 13. Tuberculosis Cases with Multidrug Resistance (MDR) on Initial or Final Drug Susceptibility Testing*: California, 2003 2012 Number of MDR Tuberculosis Cases Initial Susceptibility Test 41 36 37 34 28 Final Susceptibility Test 36 32 33 25 16 *Cases with resistance to at least isoniazid and rifampin reported on the Initial Drug Susceptibility Report (Follow-up 1) or on the Case Completion Report (Follow-up 2) 10

Deaths in Persons with Tuberculosis: California, 2003 2012 Number of Deaths Percent of Cases Died During Treatment Died Before Starting Treatment Dead at Diagnosis Percent Dying with Tuberculosis What are the implications for public health practice? Continued vigilance, surveillance, and active prevention measures are needed to reach the TB elimination. To continue making strides toward elimination, alignment of domestic TB control activities with international TB control initiatives is needed to address increasing disparities between U.S. born and foreign born persons. Treatment of persons at high risk with latent Mycobacterium tuberculosis infection is also needed to address this disparity. CDC MMWR 2015; 64(10); 265 269 32 The Challenges of Latent TB Infection Preventing TB disease by detecting and treating those with latent TB infection (LTBI) is a cornerstone of the U.S. strategy for TB elimination. LTBI is not reportable It is estimated that more than 11 million people in the U. S. (including 2.5 million in California*) have LTBI If not treated, about 5 to 10 percent of people with LTBI will develop TB disease. (~550,000 to 1.1 million people in the U.S.) Source: CDC TB Epidemiologic Studies Consortium, http://www.cdc.gov/tb/topic/research/tbesc/default.htm * California estimate derived from Census population data in 2013 and native born and foreignborn LTBI prevalence estimates in Bennett et al., Am J Respir Crit Care Med 2008;177:348 55. 33 11

Common Risk Factors for Progression from TB infection to active disease Risk factor Relative Risk (95% CI) Advanced, untreated HIV 9.9 (8.7-11) infection Close contact to infectious TB 6.1 (5.5 6.8) Radiographic evidence of old, healed, untreated TB 5.2 (3.4 8.0) Prednisone treatment 2.8 (1.7 4.6) Chronic renal failure 2.4 (2.1 2.8) TNF-α antagonist treatment 2.0 (1.1 3.5) Diabetes (poorly controlled) 1.7 (1.5 2.2) Underweight 1.6 (1.1 2.2) Smoking 1.5 (1.1 2.2) 34 Source: Horsburgh et al. New Engl J Med 2011; 364(15):1441 8. CI=confidence interval Medical risk factors for progression to TB disease, TB cases in CA, 2013 N % Diabetes 540 24.9 Non HIV immunosuppressive condition 112 5.2 End stage renal disease 77 3.6 TNF α antagonist treatment 20 0.9 Post organ transplantation 15 0.7 At least one medical risk factor 35% 35 Summary Case count ~ 9,500 new cases of TB per year in the U.S. ~ ¼ of cases in the U.S. occur in California Disease incident rate Declining, but the pace of decline has slowed since ~2000 The decline from 2013 to 2014 was the smallest in over a decade California s rate nearly twice that of the U.S. (5.6 vs. 3.0 in 2014) Certain groups disproportionately affected Men (e.g., among 45+ years) Foreign born Race/ethnicity disparities TB Deaths ~9% of TB case patients die 36 12

Summary HIV 7% of TB cases in the U.S. and 3.5% of cases in CA are HIV positive Other Medical Risk Factors More than 1/3 of TB cases in CA have at least one medical condition known to increase risk of progression from TB infection to disease Diabetes most common (1/4 of TB cases) Drug Resistance Isoniazid and multidrug resistance are higher among foreign born than among U.S. born LTBI An estimated 11 million people in the U.S. (2.5 million in CA) have LTBI Majority of cases of TB disease that occur in foreign born patients result from reactivation of LTBI Prioritizing TB screening for groups with elevated LTBI prevalence and medical risk of progression from LTBI to TB may help prevent future TB cases 37 References CDC. Reported Tuberculosis in the United States, 2013. Atlanta, GA: U.S. Department of Health and Human Services, CDC Tuberculosis Control Branch. Report on Tuberculosis in California,2014. Richmond, CA: California Department of Public Health 38 Acknowledgements Peter Oh Lisa Pascopella Saul Kanowitz Janice Westenhouse Pennan Barry 39 13